{{Rsnum
|rsid=3217901
|Gene=CCND2
|Chromosome=12
|position=4296223
|Orientation=plus
|GMAF=0.3916
|Gene_s=CCND2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 42.5 | 19.5
| HCB | 19.7 | 46.7 | 33.6
| JPT | 21.2 | 44.2 | 34.5
| YRI | 78.2 | 21.1 | 0.7
| ASW | 66.7 | 33.3 | 0.0
| CHB | 19.7 | 46.7 | 33.6
| CHD | 27.5 | 45.9 | 26.6
| GIH | 18.8 | 48.5 | 32.7
| LWK | 87.3 | 12.7 | 0.0
| MEX | 13.8 | 55.2 | 31.0
| MKK | 71.8 | 26.3 | 1.9
| TSI | 39.2 | 51.0 | 9.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23266556
  |Trait=Colorectal cancer
  |Title=Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-wide Meta-analysis.
  |RiskAllele=G
  |Pval=3E-7
  |OR=1.10
  |ORtxt=[1.06-1.14]
  |OA=1
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=18281541
|Title=Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
|OA=1
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}